We will be closed on Saturday July 13 due to facilities work.
Today's Hours: 12:00pm - 6:00pm


Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    edited by David W. Dempster, Jane A. Cauley, Mary L. Bouxsein, Felicia Cosman.
    -- Volume 1. Part I. Introduction. The nature of osteoporosis
    The bone organ system: form and function
    Part II. Developmental, cellular and molecular biology of bone. Development of the skeleton
    The skeletal stem cell
    Osteoclast biology
    Osteoblast biology: developmental origin and interactive nature of osteoblasts
    The regulatory role of matrix proteins in mineralization of bone
    Part III. Skeletal hormones and regulatory factors. Parathyroid hormone and parathyroid hormone-related protein
    Skeletal growth factors
    WNT signaling in skeletal homeostasis and diseases
    Part IV. Biomechanics and mechanobiology. The mechanical behavior of bone
    Cellular and molecular mechanotransduction in bone
    Adaptation of skeletal structure to mechanical loading
    Biomechanics of hip and vertebral fractures
    Part V. Epidemiology of osteoporosis. Epidemiologic methods in studies of osteoporosis
    Genetics of osteoporosis
    Race, ethnicity, and osteoporosis
    Geographic variability in the incidence of hip and vertebral fractures
    Nutrition and osteoporosis
    Physical activity, exercise and skeletal health
    Reproductive and hormonal factors and the risk for osteoporosis
    Clinical and epidemiological studies: skeletal changes across menopause
    Osteoporosis in men: what is similar and what is different?
    Falls as risk factors for fracture
    Impact of physical characteristics and lifestyle factors on bone density and fractures
    Imminent fracture risk and disability post fracture
    Economics of osteopososis
    Part VI. General pathophysiology of osteoporosis. Skeletal heterogeneity and the purposes of bone remodeling
    On the evolution and contemporary roles of bone remodeling
    Estrogen deficiency and the pathogenesis of osteoporosis
    Cytokines and the pathogenesis of osteoporosis
    Bone and fat
    Bone, muscle, and sarcopenia
    Bone mineral acquisition in utero and during infancy and childhood
    Osteoporosis in childhood and adolescence
    Osteoporosis in premenopausal women, pregnancy, and lactation
    Bone and the microbiome
    Volume 2. Part VII. Impact of comorbidity and medications on skeletal health. Immobilization osteoporosis
    Osteoporosis in neurological disorders: Parkinson’s disease, stroke, and multiple sclerosis
    Effects on the skeleton from medications used to treat non-skeletal disorders
    Osteoporosis associated with gastrointestinal disorders; celiac and inflammatory bowel diseases
    Osteoporosis associated with eating disorders
    Glucocorticoid-induced osteoporosis and Cushing's syndrome
    Thyroid hormone, thyroid medication, and the skeleton
    The skeletal actions of parathyroid hormone in primary hyperparathyroidism
    Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis
    Human immunodeficiency virus and osteoporosis
    Diabetes, diabetic medications, and risk of fracture
    Skeletal health after bariatric surgery
    Osteoporosis in organ transplant patients
    Osteoporosis associated with rheumatologic disorders
    Osteoporosis associated with chronic kidney disease
    Relationship between periodontal disease, tooth loss and osteoporosis
    Impact of breast cancer and its treatment on bone loss and fracture risk – pathophysiology and management
    Management of bone health in men with prostate cancer
    Impact of MGUS and myeloma on skeletal health
    Renal stone disease, hypercalciuria and osteoporosis: use of thiazides and alkali for osteoporosis
    Sleep disorders and osteoporosis
    Part VIII. Diagnosis and evaluation. Evaluation of the osteoporosis patient
    Who should be screened for osteoporosis?
    Vertebral fracture identification
    Noninvasive imaging techniques and fracture risk assessment
    Biochemical markers of bone turnover in osteoporosis
    A comparison of fracture risk assessment tools
    Part IX. Patient management. Orthopedic aspects of osteoporosis
    Fall prevention interventions
    Exercise and other physical therapy interventions in the management of osteoporosis
    Calcium and vitamin d in the management of osteoporosis
    Nutrients beyond calcium and vitamin d to treat osteoporosis
    Condition still critical: compliance and persistence with osteoporosis medications
    Part X. Pharmacotherapeutics. Estrogen and estrogen analogs for prevention and treatment of osteoporosis
    Bisphosphonates pharmacology and use in the treatment of osteoporosis
    Denosumab for the treatment of osteoporosis
    Teriparatide and abaloparatide treatment for osteoporosis
    Calcitonin in osteoporosis
    Long-term bisphosphonate treatment: continuation and interruption
    Romosozumab in the treatment of postmenopausal osteoporosis
    Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs
    Part XI. New directions. Long term treatment strategies and goal directed therapy.
    Digital Access ClinicalKey 2021
    Print Access Request
    Call Number
    Books: General Collection (Downstairs)
    RC648 .O85 2021